Dysfunction of PINK1 related pathway has been reported in patients with Parkinson’s and Alzheimer’s diseases (Ye et al., 2015; Martin-Maestro et al., 2016), which makes it a candidate therapeutic target for those diseases (Du et al., 2017). This evidence concerns the gene PINK1 and Parkinson disease.